Cordis announced new data from two major peripheral studies evaluating its Selution SLR drug-eluting balloon. The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium in London. It … [Read More...] about Cordis shares positive study results from multiple drug-eluting balloon studies
Main Content
Sponsored Content
Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Featured Posts
Cordis shares positive study results from multiple drug-eluting balloon studies
Cordis announced new data from two major peripheral studies evaluating its Selution SLR drug-eluting balloon. The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium in London. It … [Read More...] about Cordis shares positive study results from multiple drug-eluting balloon studies
Medtronic submits interoperable insulin pump to FDA to advance collaboration with Abbott
Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin pump. Clearance would enable system integration with a continuous glucose monitor (CGM) sensor based on Abbott's … [Read More...] about Medtronic submits interoperable insulin pump to FDA to advance collaboration with Abbott
Data backs Boston Scientific drug-eluting stent
Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD. The company shared multiple new clinical data sets at Charing Cross 2025 in London today. Findings reinforced the growing body of … [Read More...] about Data backs Boston Scientific drug-eluting stent
Biolinq closes $100M Series C funding round for biosensor platform
Biolinq said today it has closed a $100 million Series C funding round to advance its biosensor platform. "This financing will bolster Biolinq’s commercial readiness efforts while we pursue regulatory approval for the first intradermal glucose … [Read More...] about Biolinq closes $100M Series C funding round for biosensor platform
Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M
Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million (CHF 420 million). Burgdorf, Switzerland–based Ypsomed says the sale helps it focus on strengthening its position in the … [Read More...] about Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M
Abbott launches universal FreeStyle Libre CGM app in U.S.
Abbott (NYSE: ABT) recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 continuous glucose monitoring systems. “By listening to our customers, we developed a universal app with enhanced features to … [Read More...] about Abbott launches universal FreeStyle Libre CGM app in U.S.
Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the MiniMed 780G. Approval provides more options for users of the automated insulin delivery (AID) system, which can also work with the … [Read More...] about Medtronic wins FDA nod for new Simplera Sync CGM with MiniMed 780G
Tidepool achieves new certification for open-source quality management system
Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS. Palo Alto, California-based Tidepool, a non-profit diabetes data management group, develops open-source technology for the … [Read More...] about Tidepool achieves new certification for open-source quality management system
Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe
Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe. FORGETDIABETES aims to develop a long-term automated insulin delivery system. This system should enable optimal glucose control … [Read More...] about Glucotrack to bring implantable CBGM to automated insulin delivery system initiative in Europe
Study says smart infusion pump interoperability can enhance medication delivery
A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration. According to the study's abstract, medication administration issues remain a persistent issue in the U.S. Investigators … [Read More...] about Study says smart infusion pump interoperability can enhance medication delivery
In case you missed it
- Satio, Nanowear collab to bring AI-powered biomarkers to drug delivery
- Aptar reports positive adherence results with iPump dose software
- Retractable Technologies cuts workforce as it reduces reliance on China amid trade war
- Dexcom wins FDA nod for 15-day CGM
- Doctors issue call to action to eliminate barriers to automated insulin delivery
- How ICU Medical plans to mitigate tariff impact
- Satio completes development, testing of remotely controllable, at-home intradermal drug delivery system
- Medtronic has a new leader in its Diabetes unit
- Insulet launches Omnipod 5 in Canada
- ICU Medical launches new category of infusion pumps
- U-Pump takes next steps with AI-powered insulin patch pump
- Embecta shares study highlighting need for training, standardization in insulin delivery
- Glucotrack expects FDA IDE for implantable CBGM this year
- SiBionics unveils ‘world’s thinnest’ CGM, earns CE mark
- Dexcom picks longtime Masimo exec as next CCO
Clinical Trials
Cordis shares positive study results from multiple drug-eluting balloon studies
Cordis announced new data from two major peripheral studies evaluating its Selution SLR drug-eluting balloon. The Miami Lakes, Florida-based company presented 12-month results from the SUCCESS PTA study at the Charing Cross Symposium in London. It then shared SELUTION SFA Japan three-year results today at the Japan Endovascular Treatment Conference in Osaka. According to Cordis, the studies […]
Data backs Boston Scientific drug-eluting stent
Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD. The company shared multiple new clinical data sets at Charing Cross 2025 in London today. Findings reinforced the growing body of evidence supporting the Eluvia stent for treating peripheral artery disease (PAD) — particularly in the superficial femoral […]
R3 Vascular reports first patient treated in next-gen drug-eluting scaffold study
R3 Vascular announced today that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting bioresorbable scaffold. Dr. Brian DeRubertis of New York-Presbyterian and Weill Cornell Medicine treated the first patient. The trial evaluates the company’s next-generation Magnitude drug-eluting bioresorbable scaffold for below-the-knee peripheral arterial disease (PAD). Mountain View, California-based R3 […]
Study says smart infusion pump interoperability can enhance medication delivery
A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration. According to the study’s abstract, medication administration issues remain a persistent issue in the U.S. Investigators believe that smart infusion pump interoperability with electronic health records (EHRs) could potentially reduce IV errors. Smart infusion pumps safely deliver IV medications […]
Aptar reports positive adherence results with iPump dose software
Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication adherence. The SPEED survey looked at iPump’s effect on adherence to Stallergenes Greer’s sublingual liquid immunotherapy (SLIT). Stallergenes Greer will present findings at the CFA congress (Congrès Francophone d’Allergologie) in Paris this week. iPump, developed in conjunction with […]
